Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Burning Rock Biotech Ltd

BNR
Current price
7.55 USD +0.05 USD (+0.67%)
Last closed 7.55 USD
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 77 453 184 USD
Yield for 12 month +176.56 %
1Y
3Y
5Y
10Y
15Y
BNR
21.11.2021 - 28.11.2021

Burning Rock Biotech Limited primarily develops and sells cancer therapy selection tests in the People's Republic of China. It operates through three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. The company also provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients, as well as Magnis BR-customized version of its principal products. In addition, it offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, IMPACT Therapeutics, Boehringer Ingelheim, and Merck KGaA. The company was founded in 2014 and is headquartered in Guangzhou, the People's Republic of China. Address: No. 5, Xingdao Ring Road North, Guangzhou, China, 510005

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.02 USD

P/E ratio

Dividend Yield

Current Year

+75 602 431 USD

Last Year

+79 232 208 USD

Current Quarter

+17 033 353 USD

Last Quarter

+17 033 353 USD

Current Year

+51 096 122 USD

Last Year

+53 461 111 USD

Current Quarter

+10 988 366 USD

Last Quarter

+10 988 366 USD

Key Figures BNR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -537 868 992 USD
Operating Margin TTM -137.36 %
PE Ratio
Return On Assets TTM -31.84 %
PEG Ratio
Return On Equity TTM -67.85 %
Wall Street Target Price 4.02 USD
Revenue TTM 537 435 008 USD
Book Value 75.01 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -14.9 %
Dividend Yield
Gross Profit TTM 380 039 000 USD
Earnings per share -8.98 USD
Diluted Eps TTM -8.98 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -121.63 %

Dividend Analytics BNR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BNR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 15.05.2024
Dividend Date

Stock Valuation BNR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.0032
Price Sales TTM 0.1452
Enterprise Value EBITDA 0.01
Price Book MRQ 0.6541

Financials BNR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BNR

For 52 weeks

5.72 USD 27.6 USD
50 Day MA 7.65 USD
Shares Short Prior Month 402 414
200 Day MA 9.18 USD
Short Ratio 15.42
Shares Short 54 711
Short Percent 0.45 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds


S

SX7EEX

14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics